Do you provide GDP-compliant pharmaceutical transport?

Yes, our pharmaceutical shipments follow GDP-aligned procedures under EU Guidelines 2013/C 343/01, with validated vehicles and continuous temperature monitoring.

Has pharmaceutical transport compliance become stricter recently?

Yes, temporary COVID-era flexibilities on GDP certificate validity ended in 2025, and competent authorities have resumed full on-site inspections.

How do you help prevent falsified medicines entering the supply chain?

We maintain clear chain-of-custody documentation aligned with the Falsified Medicines Directive's serialisation requirements, supporting the unique identifier and EMVS verification system already in place on medicine packaging.

What temperature range do vaccines and biologics need?

Most require +2°C to +8°C, though some frozen biologics need significantly lower temperatures. We confirm the specific requirement for your product before booking.

Can you transport small, single-patient batches like cell and gene therapies?

Yes. We can arrange dedicated rather than consolidated transport for time-critical, irreplaceable batches where consolidation risk isn't acceptable.

Pharmaceuticals & Healthcare Transport

Pharmaceuticals & Healthcare - GDP-Compliant Pharma Logistics

A pharmaceutical shipment isn't just cargo that needs to stay cold - it's cargo that needs to prove, on paper, that it stayed within a validated temperature range the entire journey, and that it hasn't been tampered with along the way. Cargo Logistic Solutions runs GDP-aligned pharmaceutical transport across Europe, with the documentation and chain-of-custody controls that regulators and buyers now expect as standard.

What Pharmaceuticals & Healthcare Covers

This category covers medicinal products, active pharmaceutical ingredients (APIs), and healthcare goods regulated under EU Good Distribution Practice (GDP) rules - a different regulatory framework to general Temperature-Controlled Freight or Food & Perishables, both of which cover cold chain cargo but under hygiene rather than pharmaceutical distribution law. GDP (Guidelines 2013/C 343/01, plus 2015/C 95/01 for active substances) governs how medicines are stored, transported, and documented from manufacturer to pharmacy.

We run this cargo with validated vehicles and continuous temperature logging, treating documentation as part of the delivery, not paperwork attached afterward.

Why Pharma Transport Carries More Weight Than It Used To

COVID-era flexibilities are over. Temporary extensions to GDP certificate validity, granted during the pandemic, ended in 2025 - national competent authorities have resumed full on-site inspections, which raises the compliance bar for every link in the chain, including transport.
Falsified medicines are a growing, documented problem. Regulatory enforcement data from early 2026 shows a sharp rise in intercepted falsified and illegal medicine consignments compared to 2024 - a significant share involving high-demand categories like GLP-1 medications. Chain-of-custody control during transport is part of what keeps a shipment out of that statistic.
Serialisation is now digital, not just physical. Under the Falsified Medicines Directive, each pack carries a unique identifier in a 2D barcode, verified against the EU Medicines Verification System (EMVS) - transport documentation needs to align with this digital trail, not just a sealed box.
Personalised medicine raises the stakes. Cell and gene therapies often move as single-patient, irreplaceable batches - a distribution failure here isn't a delayed delivery, it's a lost treatment.

Temperature and Handling Requirements by Product Type

Product category	Typical range	Key requirement
Standard medicines, tablets	+15°C to +25°C (controlled ambient)	Validated vehicle, continuous monitoring
Biologics, vaccines	+2°C to +8°C	Tight tolerance; excursion can render the batch unusable
Frozen biologics	−18°C to −25°C or lower (product-specific)	No thaw-refreeze tolerance
Active pharmaceutical ingredients (APIs)	Product-specific	Governed separately under Guideline 2015/C 95/01

What Affects Pharmaceutical Transport Cost

Temperature validation requirements - vehicles with documented qualification and continuous monitoring cost more than standard reefer transport.
Serialisation and chain-of-custody documentation - shipments requiring full EMVS-aligned traceability need more administrative handling than standard cargo.
Insurance value - pharmaceutical cargo often carries high declared value, particularly for biologics, affecting the insurance component.
Distance and border crossings - cross-border pharma shipments require GDP-compliant handling at each point, including customs.
Security requirements - high-value or high-theft-risk medicines may require additional security measures during transit and storage.
Batch size and urgency - small, time-critical batches (including personalised medicine) often require dedicated rather than consolidated transport.

Why Choose Cargo Logistic Solutions for Pharmaceutical Transport

We treat GDP compliance as the baseline, not an add-on - validated vehicles, continuous temperature logging, and documentation that holds up if a competent authority asks for it. Every shipment is insured, and our dedicated logistics contact tracks temperature continuity and chain-of-custody from collection to delivery. With offices in Poland, Spain, Germany and the UK, we cover the routes European pharmaceutical manufacturers and distributors rely on. Pharmaceuticals and healthcare is one of the core cargo types we handle alongside food and industrial equipment.

Moving medicines, biologics, or healthcare products? Get a quote for your pharmaceutical transport - we'll confirm temperature validation, documentation, and security requirements before booking.